Accelerating Early Drug Development with Translational Pharmaceutics: Mark Egerton, PhD, chief executive officer of Quotient Sciences, shares insights on a new approach to accelerate drug development, which integrates formulation development, real-time adaptive GMP manufacturing, and clinical research within a single platform
Get full text
Journal Article